
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Edinburgh Worldwide Investment Trust Plc | LSE:EWI | London | Ordinary Share | GB00BHSRZC82 | ORD 1P |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
157.80 | 159.00 | 160.20 | 158.20 | 159.80 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 73.25M | 71.68M | 0.1930 | 8.24 | 595.59M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
13:35:26 | AT | 292 | 158.20 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
11/3/2025 | 12:32 | UK RNS | Edinburgh Worldwide Inv Trust PLC Net Asset Value(s) |
10/3/2025 | 16:55 | UK RNS | Edinburgh Worldwide Inv Trust PLC Transaction in Own Shares |
10/3/2025 | 16:41 | UK RNS | Edinburgh Worldwide Inv Trust PLC Holding(s) in Company |
10/3/2025 | 12:05 | UK RNS | Edinburgh Worldwide Inv Trust PLC Net Asset Value(s) |
07/3/2025 | 16:18 | UK RNS | Edinburgh Worldwide Inv Trust PLC Net Asset Value(s) |
06/3/2025 | 16:44 | UK RNS | Edinburgh Worldwide Inv Trust PLC Transaction in Own Shares |
06/3/2025 | 11:27 | UK RNS | Edinburgh Worldwide Inv Trust PLC Net Asset Value(s) |
05/3/2025 | 16:40 | UK RNS | Edinburgh Worldwide Inv Trust PLC Transaction in Own Shares |
05/3/2025 | 11:28 | UK RNS | Edinburgh Worldwide Inv Trust PLC Net Asset Value(s) |
04/3/2025 | 11:47 | UK RNS | Edinburgh Worldwide Inv Trust PLC Net Asset Value(s) |
Edinburgh Worldwide Inve... (EWI) Share Charts1 Year Edinburgh Worldwide Inve... Chart |
|
1 Month Edinburgh Worldwide Inve... Chart |
Intraday Edinburgh Worldwide Inve... Chart |
Date | Time | Title | Posts |
---|---|---|---|
11/2/2025 | 12:22 | Edinburgh Worldwide Investment Trust | 104 |
17/1/2025 | 09:52 | Webinar: Saba Capital’s Campaign and Its Implications for Shareholders | - |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
13:35:26 | 158.20 | 292 | 461.94 | AT |
13:35:26 | 158.20 | 5,000 | 7,910.00 | AT |
13:31:57 | 158.46 | 352 | 557.77 | O |
13:25:48 | 158.55 | 11,831 | 18,758.05 | O |
13:24:54 | 159.40 | 50 | 79.70 | O |
Top Posts |
---|
Posted at 11/3/2025 08:20 by Edinburgh Worldwide Inve... Daily Update Edinburgh Worldwide Investment Trust Plc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the London Stock Exchange with ticker EWI. The last closing price for Edinburgh Worldwide Inve... was 160.40p.Edinburgh Worldwide Inve... currently has 371,315,908 shares in issue. The market capitalisation of Edinburgh Worldwide Inve... is £590,392,294. Edinburgh Worldwide Inve... has a price to earnings ratio (PE ratio) of 8.24. This morning EWI shares opened at 159.80p |
Posted at 17/1/2025 09:52 by sharesoc Date: 24th January 2025
Time: 1:00 PM
Format: Online WebinarSaba Capital, a US hedge fund, has recently called for general meetings at seven investment trusts: Baillie Gifford US Growth Trust (USA), Edinburgh Worldwide (EWI), Keystone Positive Change (KPC), Henderson Opportunities Trust (HOT), European Smaller Companies Trust (ESCT), CQS Natural Resources Growth & Income (CYN), Herald Investment Trust (HRI). Unless other shareholders vote at these general meetings, Saba’s resolutions will pass, enabling Saba to take control of these trusts. In this webinar, an expert panel, including Ros Altmann, James Carthew, and Richard Stone, will explore the implications of these developments, focusing on the broader issues surrounding shareholder democracy. Additionally, there will be a concise presentation on how shareholders, particularly those holding shares via brokers or platforms, can ensure their voting rights are effectively exercised. Learn more and register here: |
Posted at 03/1/2025 08:15 by quepassa Thanks.See Post 88! Please check in more frequently as it is a quiet thread and an interesting time when EWI is being attacked by Saba. I will repeat post 88 again for ease of reference. Please note that Rigetti went up another 30% yesterday -so percentage rises may now be updating/increasing. |
Posted at 03/1/2025 07:40 by 18bt QP an interesting post by you on the SMT thread re PSi Quantum. Worth reposting here. Not a greatly used thread but have a small holding in EWI |
Posted at 31/12/2024 11:31 by quepassa With Saba Capital beating the door down, one can but hope that this could be construed as a trigger event where the complete unlisted portfolio is revalued at year end December 2024, rather than waiting for the regular revaluation cycles.Let's hope EWI revalue the whole unlisted portfolio now. Either way, the January Monthly Fact Sheet will be eagerly awaited. ALL IMO. DYOR. QP |
Posted at 17/12/2024 15:12 by quepassa 1.Astonished that person at BG said they could not reveal how many SpaceX shares held by EWI. That is public knowledge which they already reveal in their full portfolio valuations. As at 31/10/24, EWI had the following SpaceX positions/number of shares:- SpaceX Class A 3,190,457 SpaceX Class C 984,441 SpaceX Series J Pref 22,445,089 SpaceX Series K Pref 10,231,841 SpaceX Series N Pref 49,480,061 2. The value of the overall SpaceX holding is easy to calculate As at 30/11/24, , the overall Fund value of EWI was £788.81 million Spacex was 8.4% of the fund which means the Spacex holding was valued at £66.26 million at the end of last month - two weeks ago. 3. My guess is that the SpaceX holding has not yet been revalued to reflect the most recent likeley uplift in the value of Spacex at the new Tender Price - perhaps because it has not yet been formally confirmed that the deal has gone ahead despite highly reliable rumours. 4. You will need to make assumptions about the different prices of common stock compared to pref shares. However, if I were a betting man my guess is that EWI's Spacex holding as a whole is still valued at the summer Company valuation of $210 billion derived from actual shares sales at that time but that the latest mooted revaluation to $350 billion is still awaiting confirmation until ink has dried. ALL IMO. DYOR. QP |
Posted at 17/12/2024 13:35 by joedjoed Re impact of SpaceX price rise: I contacted the investor relations team at EWI who were very responsive but not able to help. I was told the number of shares held cannot be disclosed due to the NDA with SpaceX. I then asked what the share prices were for the last valuation which would enable that to be backed out. This was also confidential. Seems odd to me.If we use the hxxps://notice.co/c/ |
Posted at 12/12/2024 19:20 by kkk16 Trying to do some maths on the $185 share valuation of Space x in relation to Edinburgh worldwide. Any views? |
Posted at 13/12/2023 11:08 by quepassa Wow.Privately owned SpaceX now valued close to $180 billion in new tender offer at $97 per share. According to trusted Bloomberg today. A significant uplift in SpaceX valuation which should in due course be reflected in both Scottish Mortgage and even more in Edinburgh Worldwide . all imo. dyor. qp |
Posted at 15/6/2023 20:34 by takeiteasy In the COVID tech recovery this shot up and this time around the NASDAQ is well up in 2023 and this part of the market heads ever lower. I looked at some comments today to understand the market conditions better to understand how someone else in this area of the market assessed things. I.e. when we will know there is any sort of recovery to come back in?BIOG trust update today... Macroeconomic factors rather than industry fundamentals continued to dominate portfolio performance during the fiscal year. The fiscal year began with weakness in the biotech sector in April and May 2022, driven by continued investor concerns about rising interest rates. Continued rate hikes by the U.S. Federal Reserve (the Fed) to combat inflation drove down share prices for unprofitable technology stocks broadly, including emerging biotech. Valuations for emerging biotech, which had reached 20-year lows, appeared to bottom out in May and June. In August, drug pricing legislation in the U.S. was passed as part of the Democrats' "Inflation Reduction Act". While the bill allows for limited drug price negotiation by Medicare starting in 2026, the provisions appear manageable for the industry and passage of the bill cleared a longstanding political overhang for the sector. By the end of September, the biotech sector had begun staging a recovery from depressed levels. In October, a disappointing round of earnings from large capitalization (cap) technology stocks like Amazon and Meta and growing recession concerns appeared to draw generalist inflows into the defensive pharmaceutical sector and large cap biotech. Large cap biotech outperformance continued in November, but small cap biotech began outperforming in December, and January 2023. Unfortunately, interest rate expectations became more hawkish in February when the U.S. announced a lower-than-expected unemployment rate and higher-than-expected inflation, sending small cap shares back down. In March, the unexpected failure of Silicon Valley Bank (SVB) had a particularly negative impact on small cap biotech, many of which were SVB clients. Even though absolute cash exposure to SVB for most biotech companies was minimal, renewed risk aversion due to the concerns over the banking system caused large cap biotech to significantly outperform small cap biotech. This trading dynamic had a particularly detrimental impact on the Company's relative performance versus the Benchmark, given that the Company is significantly overweight small cap names and underweight large cap names. The drawdown in March accounted for virtually all of the underperformance of the Company's NAV versus the Benchmark for the fiscal year. Encouragingly, the Company has seen a rebound in relative performance in April and May 2023, which we hope signals a more sustained recovery. dyor etc |
Posted at 06/5/2022 14:29 by campervan1 I was just watching the tumble weed blowing along on this board and I came across this on the ewi website. A long and interesting history, with links to James Bond!I for one will continue to hold on through this particular storm, "if necessary lashed to the wheel". |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions